Exec Chat: New Smith & Nephew CEO Namal Nawana Outlines Growth Strategy At JP Morgan

About eight months into his role as CEO of Smith & Nephew, Namal Nawana has revamped the firm's leadership team and created strategic imperatives to put the British medical device giant on the growth track. Medtech Insight sat down with Nawana at this year's JP Morgan Healthcare Conference in San Francisco to learn more about his plans for growing Smith & Nephew.

Luxury executive office with city view window - Image

Since Namal Nawana took the reigns as Smith & Nephew PLC's CEO last May, he's been laser-focused on growth. Nawana said early on that the British device giant has "excellent technology" across all core segments – orthopedics, sports medicine and wound management – but he saw that less than half of Smith & Nephew's products have been growing at or above market rate.

"Within just the core areas that we operate, we estimate there's a roughly $40bn market growing at around 4%," Nawana...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business